AU3771799A - Treatment of advanced decompensated heart failure with nitric oxide donors - Google Patents
Treatment of advanced decompensated heart failure with nitric oxide donorsInfo
- Publication number
- AU3771799A AU3771799A AU37717/99A AU3771799A AU3771799A AU 3771799 A AU3771799 A AU 3771799A AU 37717/99 A AU37717/99 A AU 37717/99A AU 3771799 A AU3771799 A AU 3771799A AU 3771799 A AU3771799 A AU 3771799A
- Authority
- AU
- Australia
- Prior art keywords
- treatment
- heart failure
- nitric oxide
- oxide donors
- decompensated heart
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010019280 Heart failures Diseases 0.000 title 1
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical class O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 title 1
- 239000002840 nitric oxide donor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8361898P | 1998-04-30 | 1998-04-30 | |
| US60083618 | 1998-04-30 | ||
| PCT/US1999/009330 WO1999055317A2 (en) | 1998-04-30 | 1999-04-30 | Treatment of advanced decompensated heart failure with nitric oxide donors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3771799A true AU3771799A (en) | 1999-11-16 |
Family
ID=22179553
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU37717/99A Abandoned AU3771799A (en) | 1998-04-30 | 1999-04-30 | Treatment of advanced decompensated heart failure with nitric oxide donors |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU3771799A (en) |
| WO (1) | WO1999055317A2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6656966B2 (en) | 2000-06-22 | 2003-12-02 | Nitromed, Inc. | Nitrosated and nitrosylated taxanes, compositions and methods of use |
| US20100316622A1 (en) * | 2007-11-02 | 2010-12-16 | University Of Miami | Diagnosis and treatment of cardiac disorders |
-
1999
- 1999-04-30 AU AU37717/99A patent/AU3771799A/en not_active Abandoned
- 1999-04-30 WO PCT/US1999/009330 patent/WO1999055317A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999055317A2 (en) | 1999-11-04 |
| WO1999055317A3 (en) | 2000-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0815838A3 (en) | External skin treatment composition | |
| AU7819994A (en) | Nitric oxide treatment | |
| AU3201095A (en) | Substituted thiazoles for the treatment of inflammation | |
| AU7085000A (en) | An automatic external cardioverter/defibrillator with cardiac rate detector and method of operating the same | |
| EP0204597A3 (en) | Use of alfuzosine in the treatment of urinary affections | |
| AU2093392A (en) | Treatment of congestive heart failure | |
| AU6579498A (en) | Compounds and methods for the diagnosis and treatment of (ehrlichia) infection | |
| AU2682595A (en) | Laminated body and method of manufacturing the same | |
| AU9471598A (en) | Treatment of congestive heart failure with growth hormone secretagogues | |
| AU2630295A (en) | 2-acylaminopropanol compound and medical composition | |
| EP1144639A3 (en) | Compounds and methods for the diagnosis and treatment of ehrlichia infection | |
| AU2424895A (en) | Substituted spirodienes for the treatment of inflammation | |
| AU4774597A (en) | Use of 1-hydroxy-2-pyridones for the treatment of skin infections | |
| AU1850695A (en) | Treatment of diabetic nephropathy with valsartan | |
| AU8508398A (en) | Treatment of diabetes with synthetic beta cells | |
| AU6528494A (en) | Nitric oxide combination therapy | |
| AU3198795A (en) | Use of nitric oxide or nitric oxide adducts to preserve platelets | |
| AU6149296A (en) | Expression of human inducible nitric oxide synthase | |
| AU3086097A (en) | Nitric oxide inhalation for the prophylaxis and treatment of inflammatory response | |
| AU2068295A (en) | Skin treatment composition | |
| AU3771799A (en) | Treatment of advanced decompensated heart failure with nitric oxide donors | |
| AU6927894A (en) | 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions | |
| AUPM424894A0 (en) | Treatment of electrolyte solutions | |
| AU7609298A (en) | Treatment of heart failure with growth hormone | |
| AU7854094A (en) | Use of amiodarone for the treatment of heart failure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |